We have adjusted our estimates ahead of Q2 reporting (calendar Q1) on 7 May 2024. The changes are small with our forecasts remaining consistent with guidance. However, with the shares expensive, despite pronounced year to date weakness, we remain Underperform.
We do not consider the changes to be material; our rating is unchanged.
